Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1713 of 6351
-
New heart procedure tested for AFib control
Disease control OngoingThe ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can ashwagandha boost chemo in ovarian cancer? new trial aims to find out
Disease control Recruiting nowThe proposed study "combination therapy with liposomal doxorubicin and withaferin A (Ashwagandha, ASWD) in recurrent ovarian cancer" is focused to determine the feasibility and maximum tolerance dose of Ashwagandha with liposomal doxorubicin (DOXIL) in recurrent ovarian cancer pa…
Phase 1/2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can we predict chronic pain after breast cancer surgery?
Knowledge-focused CompletedChronic post-mastectomy pain (CPMP) is a significant issue affecting many women after mastectomy. Factors like age, treatment type, and pre-surgery pain can increase the risk of developing this condition. By evaluating these factors, CPMP can be prevented more successfully and tr…
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could empowering mothers be the key to better bedwetting care?
Symptom relief CompletedThis study aimed to evaluate the effect of the empowerment program on the knowledge, practices, and quality of life of mothers of children with nocturnal enuresis in a two-arm randomized controlled trial.
Sponsor: Cairo University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New pill combo aims to tame advanced prostate cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in subjects with advanced prostate cancer.
Phase 1/2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hearing implant shows promise for kids under five
Disease control CompletedThis study, titled "The BONEBRIDGE in Children Under Five: Premarket Clinical Investigation" (Study ID 2023BB006), looks at kids under five who have received the BONEBRIDGE BCI 602 hearing implant. This observational study, which is both retrospective (looking back) and prospecti…
Sponsor: MED-EL Elektromedizinische Geräte GesmbH • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Taurine trial: could this common supplement turn back the clock?
Symptom relief CompletedThe goal of this clinical trial is to investigate the effect of taking 4 grams of taurine by older adults on aging processes over a period of 6 months. It will also check for effects of taurine on participant's physical fitness, metabolic and cognitive functions. The main questio…
Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New patch could replace opioids for knee surgery pain
Symptom relief CompletedThis is a randomized (1:1) placebo-controlled clinical trial to determine the feasibility and effectiveness of 30-day application of NEUROCUPLE™ patch for pain reduction and opioid consumption following TKA. Results will establish NEUROCUPLE™ as an effective non-opioid postoperat…
Sponsor: nCap Medical • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Blood test could help personalize breast cancer therapy
Disease control Recruiting nowThis is a prospective study to assess the impact of biomarker driven, early therapeutic switching and delayed imaging with the incorporation of DiviTum® serum TK1 activity ("DiviTum® TKa") in patients with HR positive, HER-2 negative metastatic or unresectable breast cancer. Pati…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug duo aims to shrink head and neck tumors
Disease control Recruiting nowThe purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Participants will receive the study drugs ACR-368 and a low dose of gemcitabine once every…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New scan could spot bile duct cancers more accurately
Diagnosis Recruiting nowThe goal of this prospective observational study is to evaluate whether Gallium-68 Fibroblast Activation Protein Inhibitor (FAPI) PET/CT can improve detection, staging, and recurrence assessment in adult patients (≥18 years) with suspected or confirmed biliary tract cancers, incl…
Sponsor: Tata Memorial Centre • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New scan could predict breast cancer treatment success in days
Diagnosis Recruiting nowThis clinical trial will investigate an estrogen-regulated parameter as an early measure of endocrine therapy response: progesterone receptor (PR) protein with a progestin-based radioligand, 18F-fluorofuranylnorprogesterone (18F-FFNP). The overall purpose of this research is to t…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo aims to stall endometrial cancer in High-Risk patients
Disease control Recruiting nowThe purpose of this research study is to see if the study drugs abemaciclib and letrozole are effective and safe for participants with estrogen-receptor positive (ER+), mismatch repair proficient, tumor protein p53 (TP53) wild-type endometrial cancer. The names of the study drug…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tracks long-term safety of DMD drug vamorolone in boys
Disease control Recruiting nowThe goal of this study is to collect additional information on the safety of long-term treatment with AGAMREE® and to explore long-term clinical impact of AGAMREE® on quality of life, as assessed by standardized patient-reported outcome measures (QoL questionnaires) in male patie…
Sponsor: Catalyst Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can weightlifting beat cardio for blood sugar in pregnancy?
Disease control Recruiting nowGestational diabetes mellitus (GDM) is the most common disease during pregnancy and is characterized by an inability to regulate blood glucose (sugar) levels because of resistance to the hormone, insulin, which is responsible for getting glucose out of the blood. Aerobic training…
Sponsor: University of Central Arkansas • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New inhaler aims to quiet chronic cough
Symptom relief OngoingThis is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalation Powder (NOC-110) once daily in adults with refractory or unexplained chronic cough.
Phase 2 • Sponsor: Nocion Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Migraine prevention drug atogepant under Real-World review in korea
Prevention Recruiting nowMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the safety and effectiveness of atogepant for the preventive treatment of migraine in Korean adult patie…
Sponsor: AbbVie • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Can a dengue vaccine shield you from zika? new study investigates
Prevention CompletedZika virus (ZIKV) is an illness people can get from mosquitoes. The infection is generally mild with symptoms that include a fever, rash, red eyes, and joint pain, though most of those infected have no symptoms. Preventing ZIKV is important because if a pregnant person is infecte…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Can a smartphone app ease perinatal depression in immigrant mothers?
Symptom relief CompletedThe goal of this study is to determine the feasibility of using a psychosocial intervention culturally adapted in China to support perinatal mental well-being of Chinese immigrant pregnant women in Canada. The intervention is adapted from the Thinking Healthy Program (THP), avail…
Sponsor: Shahirose Sadrudin Premji • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a pill and patch help dual users kick the smoking habit?
Disease control Recruiting nowThe overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
Phase 4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC